Valuation: Novartis AG

Market Cap 295B 263B 243B 220B 412B 27,996B 419B 2,928B 1,159B 14,668B 1,107B 1,083B 46,244B P/E 2026 *
21.8x
P/E 2027 * 18.3x
Enterprise Value 327B 292B 269B 244B 457B 31,000B 464B 3,242B 1,283B 16,242B 1,226B 1,199B 51,206B EV / Sales 2026 *
5.67x
EV / Sales 2027 * 5.27x
Free-Float
91.66%
Yield 2026 *
2.81%
Yield 2027 * 2.94%

Last Transcript: Novartis AG

1 day-0.68%
1 week+2.65%
Current month+6.70%
1 month+8.84%
3 months+0.27%
6 months+10.08%
Current year+16.79%
1 week 123.64
Extreme 123.64
129.34
1 month 115.94
Extreme 115.94
129.34
Current year 107.68
Extreme 107.68
132.68
1 year 97.05
Extreme 97.05
132.68
3 years 81.1
Extreme 81.1
132.68
5 years 72.84
Extreme 72.84
132.68
10 years 65.09
Extreme 65.09
132.68
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Compliance Officer 58 14/04/2025
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap. Importance
18/5/26 Sell -5,200 0.0003%
4/5/26 Sell 6,800 0.0003%
17/2/26 Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-0.68%+2.65%+22.46%+51.48% 295B
-2.54%+1.31%+55.10%+120.84% 1,135B
-1.42%+3.23%+37.07%+74.26% 636B
+0.16%+0.08%+25.14%+97.36% 505B
-0.31%+3.09%+43.92%+64.55% 378B
-1.34%-0.47%+66.63%+40.56% 358B
-1.20%+3.04%+2.62%+26.97% 266B
-1.79%+1.57%+49.97%+60.87% 237B
-0.73%-0.10%+29.24%+101.19% 193B
-1.74%+0.21%-24.15%-61.87% 172B
Average -0.78%+1.97%+30.80%+57.62% 417.67B
Weighted average by Cap. -0.32%+2.56%+38.31%+76.19%

Financials

2026 *2027 *
Net sales 57.58B 51.42B 47.5B 43.05B 80.54B 5,466B 81.87B 572B 226B 2,864B 216B 212B 9,029B 61.39B 54.82B 50.64B 45.89B 85.86B 5,828B 87.28B 609B 241B 3,053B 230B 225B 9,626B
Net income 14.3B 12.77B 11.8B 10.69B 20.01B 1,358B 20.34B 142B 56.22B 711B 53.68B 52.54B 2,243B 15.94B 14.24B 13.15B 11.92B 22.3B 1,514B 22.67B 158B 62.67B 793B 59.84B 58.57B 2,500B
Net Debt 31.64B 28.26B 26.1B 23.66B 44.26B 3,004B 44.99B 314B 124B 1,574B 119B 116B 4,962B 28.7B 25.63B 23.68B 21.46B 40.14B 2,724B 40.8B 285B 113B 1,427B 108B 105B 4,500B
Projected Income Statement - Annual - Novartis AG
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
23/10/26 CHF 128.00 -0.68% 2,831,710
22/10/26 CHF 128.88 +1.58% 3,387,898
21/10/26 CHF 126.88 +0.30% 2,940,668
20/10/26 CHF 126.50 +1.85% 3,198,959
19/10/26 CHF 124.20 -0.40% 2,837,515
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Novartis AG
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
23
Last Close Price
155.16USD
Average target price
149.88USD
Spread / Average Target
-3.40%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Novartis AG
  1. Stock Market
  2. Stocks
  3. NOVN Stock